List of articles in "Drug" category - Page 256

Isavuconazole (BAL4815) is an experimental triazole antifungal. Its prodrug isavuconazonium sulfate (BAL8557) is currently in two Phase III clinical trials (SECURE and VITAL) the results of which are expected in […]

AM-411 is an analgesic drug that is a cannabinoid agonist. It is a derivative of Δ8THC substituted with an adamantyl group at the 3-position demonstrating that the binding pocket for […]

HU-308 is a drug that acts as a cannabinoid agonist. It is highly selective for the CB2 receptor subtype with a selectivity of over 5000x for CB2 vs CB1. The […]

25I-NBOMe (2C-I-NBOMe Cimbi-5) is a psychedelic drug and derivative of the substituted phenethylamine psychedelic 2C-I. It was discovered in 2003 by chemist Ralf Heim at the Free University of Berlin […]

25I-NBOH (NBOH-2CI Cimbi-27) is a derivative of the phenethylamine derived hallucinogen 2C-I. It acts as a potent agonist for the 5HT2A receptor with a Ki of 0.061nM at the human […]

5-Methyl-34-methylenedioxyamphetamine (5-Methyl-MDA) is an entactogen and psychedelic drug of the amphetamine class. It is a ring-methylated derivative of MDA and a structural isomer of MDMA.

2C-YN is an analog of phenethylamine that can be synthesized from 2C-I. Very little data exists about the pharmacological properties metabolism and toxicity of 2C-YN.

25-Dimethoxy-4-trifluoromethylamphetamine (DOTFM) is a psychedelic drug of the phenethylamine and amphetamine chemical classes. It was first synthesized in 1994 by a team at Purdue University led by David E. Nichols. […]

TCB-2 is a hallucinogen discovered in 2006 by Thomas McLean working in the lab of Prof. David Nichols at Purdue University where it was named 2C-BCB. It is a conformationally-restricted […]

Rolofylline (KW-3902) is an experimental diuretic which acts as a selective adenosine A1 receptor antagonist. It was discovered at NovaCardia Inc. which was purchased by Merck & Co. Inc. in […]